doi: 10.1001/jamanetworkopen.2023.50408 Summary Keywords obesity, anti-obesity pharmacotherapy, emerging therapies, obesity drug development, GLP-1 receptor agonists, combination therapy Citation Park C, Kim Y, Raygani S and Grunvald E (2025) A glimpse into the pipeline of anti-obesity medication development: combining multiple receptor pathways
Storage & handling Store sealed at -20C, protected from light
Research spills the beans: Glutathione can ease the hurt on cells from things like fatty liver by perking up proteins, enzymes, and those bilirubin levels for folks with liver struggles (Healthline)
The largest stroke trial, CASTA (Cerebrolysin in Acute Stroke in Asia), enrolled 1,070 patients with acute ischemic hemispheric stroke